For HCPs: MOA for CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab)
Автор: CABOMETYX® (cabozantinib)
Загружено: 2026-01-20
Просмотров: 5
Please see Full Prescribing Information for CABOMETYX (cabozantinib): https://www.cabometyxhcp.com/prescrib...
This video is intended for US healthcare professionals only.
Watch this video to explore how CABOMETYX and OPDIVO are thought to function.
OPDIVO® and the related logo is a registered trademark of Bristol-Myers Squibb Company.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: